New user? / Forgot your password?
0 Item | 0,00 €
Omethoate
| Item number | 675430 |
| CAS | 1113-02-6 |
| Formula | C5H12NO4PS |
| Molecular weight | 213,19 g/mol |
| Quantity | 1X100MG |
| storage conditions | 4 °C |
| CoA / MSDS | Retrieve CoA Retrieve MSDS |
Price | Please log in. |
Part of Product groups:
Product Variations:
Product | Catalog No./ CAS No. | Quantity | Price | |
|---|---|---|---|---|
D6-Omethoate solution |  | 680026 | 1X1ML | Please log in. |
Omethoate solution |  | 673399 | 1X5ML | Please log in. |
 | 675430 | 1X100MG | Please log in. |
| Safety Data Sheet | according to Regulation (EC) No 1907/2006 (REACH) Classifications according to Regulation (EC) No 1272/2008. Printdate 08.09.2024 |
| IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING | |
| Product name: | Omethoate |
| Catalog No.: | 675430 |
| Relevant identified uses of the substance or mixture | Identified: Laboratory chemical uses: R&D |
| Uses advised against: | HPC Standards GmbH Am Wieseneck 7 04451 Cunnersdorf Deutschland Tel. +49 34291 3372-36 Fax. +49 34291 3372-39 contact@hpc-standards.com |
| Emergency telephone number | HPC Standards Tel. +49 34291 3372-36 This number is only available during office hours. |
| HAZARDS IDENTIFICATION | 2.1 Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP] Acute toxicity, Oral (Category 2) Acute toxicity, Dermal (Category 3) Acute aquatic toxicity (Category 1) Classification according to EU Directives 67/548/EEC or 1999/45/EC Toxic if swallowed. Harmful in contact with skin. Very toxic to aquatic organisms |
| Label elements | |
| Pictogram | GHS06 skull skull GHS09 Aquatic-pollut-red Aquatic-pollut-red |
| Signal word Danger Hazard statement(s) H300 Fatal if swallowed. H311 Toxic in contact with skin. H400 Very toxic to aquatic life. Precautionary statement(s) P264 Wash hands thoroughly after handling. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/ physician. P312 Call a POISON CENTER or doctor/ physician if you feel unwell Supplemental Hazard Statements none According to European Directive 67/548/EEC as amended. Hazard symbol(s) R-phrase(s) R21 Harmful in contact with skin. R25 Toxic if swallowed. R50 Very toxic to aquatic organisms. S-phrase(s) S23 Do not breathe gas/fumes/vapour/spray. S36/37 Wear suitable protective clothing and gloves. S45 In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). S61 Avoid release to the environment. Refer to special instructions/ Safety data sheets. 2.3 Other hazards - none | |
| COMPOSITION/INFORMATION ON INGREDIENTS | 3.1 Substances Formula : C5H12NO4PS Molecular Weight : 213,19 g/mol Component Concentration Omethoate CAS-No. EC-No. Index-No. 1113-02-6 214-197-8 015-066-00-6 - |
| Formula | C5H12NO4PS |
| Molecular Weight (g/mol) | 213.19 |
| CAS-No. | 1113-02-6 |
| FIRST AID MEASURES | 4.1 Description of first aid measures General advice Consult a physician. Show this safety data sheet to the doctor in attendance. If inhaled If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. In case of skin contact Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician. In case of eye contact Flush eyes with water as a precaution. If swallowed Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. 4.2 Most important symptoms and effects, both acute and delayed Cholinesterase inhibitors can cause heavy salivation and secretion in the lungs, lachrymation, blurred vision, involuntary defecation, diarrhea, tremor, ataxia, sweating, hypothermia, lowered heart rate, and/or a fall in blood pressure as a result of their action at cholinergic nerve sites., Headache, Nausea, Vomiting, Dizziness, Drowsiness, Confusion., Weakness, Muscle cramps/spasms., Change in pupil size., Fever, Seizures., Incoordination., Convulsions, Coma. 4.3 Indication of any immediate medical attention and special treatment needed no data available |
| FIRE-FIGHTING MEASURES | 5.1 Extinguishing media Suitable extinguishing media Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 5.2 Special hazards arising from the substance or mixture Carbon oxides, nitrogen oxides (NOx), Sulphur oxides, Oxides of phosphorus 5.3 Advice for firefighters Wear self contained breathing apparatus for fire fighting if necessary. 5.4 Further information no data available |
| ACCIDENTAL RELEASE MEASURES | 6.1 Personal precautions, protective equipment and emergency procedures Wear respiratory protection. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. 6.2 Environmental precautions Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided. 6.3 Methods and materials for containment and cleaning up Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed containers for disposal. 6.4 Reference to other sections For disposal see section 13. |
| HANDLING AND STORAGE | 7.1 Precautions for safe handling Avoid contact with skin and eyes. Avoid inhalation of vapour or mist. 7.2 Conditions for safe storage, including any incompatibilities Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are opened must be carefully resealed and kept upright to prevent leakage. Recommended storage temperature: 2 - 8 °C 7.3 Specific end uses no data available |
| EXPOSURE CONTROLS/PERSONAL PROTECTION | 8.1 Control parameters Components with workplace control parameters 8.2 Exposure controls Appropriate engineering controls Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling the product. Personal protective equipment Eye/face protection Face shield and safety glasses Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Skin protection Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. Body Protection Complete suit protecting against chemicals, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Respiratory protection Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). |
| PHYSICAL AND CHEMICAL PROPERTIES | 9.1 Information on basic physical and chemical properties a) Appearance Form: liquid b) Odour no data available c) Odour Threshold no data available d) pH no data available e) Melting point/freezing point no data available f) Initial boiling point and boiling range no data available g) Flash point 100 °C - closed cup h) Evaporation rate no data available i) Flammability (solid, gas) no data available j) Upper/lower flammability or explosive limits no data available k) Vapour pressure 4,3 hPa at 20 °C l) Vapour density no data available m) Relative density 1,320 g/cm3 n) Water solubility soluble o) Partition coefficient: noctanol/ water no data available p) Autoignition temperature no data available q) Decomposition temperature no data available r) Viscosity no data available s) Explosive properties no data available t) Oxidizing properties no data available 9.2 Other safety information no data available |
| STABILITY AND REACTIVITY | 10.1 Reactivity no data available 10.2 Chemical stability no data available 10.3 Possibility of hazardous reactions no data available 10.4 Conditions to avoid no data available 10.5 Incompatible materials Bases 10.6 Hazardous decomposition products Other decomposition products - no data available |
| TOXICOLOGICAL INFORMATION | 11.1 Information on toxicological effects Acute toxicity LD50 Oral - rat - 30 mg/kg LD50 Inhalation - mouse - 4 h - 140 mg/m3 Remarks: Biochemical:Enzyme inhibition, induction, or change in blood or tissue levelsTrue cholinesterase. LC50 Inhalation - rat - 1 h - > 1.500 mg/m3 LD50 Dermal - rat - 700 mg/kg LD50 Intraperitoneal - rat - 14,400 mg/kg Remarks: Biochemical:Enzyme inhibition, induction, or change in blood or tissue levelsTrue cholinesterase. Skin corrosion/irritation no data available Serious eye damage/eye irritation no data available Respiratory or skin sensitization no data available Germ cell mutagenicity Genotoxicity in vitro - Human - lymphocyte Sister chromatid exchange Carcinogenicity IARC: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC. Reproductive toxicity no data available Specific target organ toxicity - single exposure no data available Specific target organ toxicity - repeated exposure no data available Aspiration hazard no data available Potential health effects Inhalation May be harmful if inhaled. May cause respiratory tract irritation. Ingestion May be fatal if swallowed. Skin Toxic if absorbed through skin. May cause skin irritation. Eyes May cause eye irritation. Signs and Symptoms of Exposure Cholinesterase inhibitors can cause heavy salivation and secretion in the lungs, lachrymation, blurred vision, involuntary defecation, diarrhea, tremor, ataxia, sweating, hypothermia, lowered heart rate, and/or a fall in blood pressure as a result of their action at cholinergic nerve sites., Headache, Nausea, Vomiting, Dizziness, Drowsiness, Confusion., Weakness, Muscle cramps/spasms., Change in pupil size., Fever, Seizures., Incoordination., Convulsions, Coma. Additional Information RTECS: TF8050000 |
| ECOLOGICAL INFORMATION | 12.1 Toxicity Toxicity to fish LC50 - Poecilia reticulata (guppy) - 48 mg/l - 96,0 h Toxicity to daphnia and other aquatic invertebrates EC50 - Daphnia magna (Water flea) - 0,021 mg/l - 48 h 12.2 Persistence and degradability no data available 12.3 Bioaccumulative potential no data available 12.4 Mobility in soil no data available 12.5 Results of PBT and vPvB assessment no data available 12.6 Other adverse effects Very toxic to aquatic life. |
| DISPOSAL CONSIDERATIONS | 13.1 Waste treatment methods Product Offer surplus and non-recyclable solutions to a licensed disposal company. Contaminated packaging Dispose of as unused product. |
| TRANSPORT INFORMATION | 14.1 UN number ADR/RID: 2810 IMDG: 2810 IATA: 2810 14.2 UN proper shipping name ADR/RID: TOXIC LIQUID, ORGANIC, N.O.S. (Omethoate) IMDG: TOXIC LIQUID, ORGANIC, N.O.S. (Omethoate) IATA: Toxic liquid, organic, n.o.s. (Omethoate) 14.3 Transport hazard class(es) ADR/RID: 6.1 IMDG: 6.1 IATA: 6.1 14.4 Packaging group ADR/RID: II IMDG: II IATA: II 14.5 Environmental hazards ADR/RID: yes IMDG Marine pollutant: yes IATA: no 14.6 Special precautions for user no data available |
| REGULATORY INFORMATION | This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006. 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture no data available 15.2 Chemical Safety Assessment no data available |
| OTHER INFORMATION | The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. For lab use only! |